Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
United Kingdom (pricing reform), Italy (pricing and health care reform), Germany (pricing and health care reform), France (pricing and health care reform), Poland (market access & IP), Russia WTO accession (market access), European Union (market access), Spain (IP), Japan (pricing & regulatory reform), Korea FTA (pricing, regulatory & IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price control), Turkey (transparency & market access), Algeria (transparency), Latin America Free Trade Agreements, Canada (market access -- S 242), Norway (market access), China (pricing)
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2008 · second_quarter · 2A
Agriculture
United Kingdom (pricing reform), Italy (pricing and health care reform), Germany (pricing and health care reform), France (pricing and health care reform), Poland (market access & IP), Russia WTO accession (market access), European Union (market access), Spain (IP), Japan (pricing & regulatory reform), Korea FTA (pricing, regulatory & IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price control), Turkey (transparency & market access), Algeria (transparency), Latin America Free Trade Agreements, Canada (market access -- S 242), Norway (market access), China (pricing)
Source: Senate LDA
United Kingdom (pricing reform), Italy (pricing and health care reform), Germany (pricing and health care reform), France (pricing and health care reform), Poland (market access & IP), Russia WTO accession (market access), European Union (market access), Spain (IP), Japan (pricing & regulatory reform), Korea FTA (pricing, regulatory & IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price control), Turkey (transparency & market access), Algeria (transparency), Latin America Free Trade Agreements, Canada (market access -- S 242), Norway (market access), China (pricing)
Pharmaceutical Market Access and Drug Safety Act of 2007
Client: ELI LILLY AND COMPANY · Firm: ELI LILLY AND COMPANY
United Kingdom (pricing reform), Italy (pricing and health care reform), Germany (pricing and health care reform), France (pricing and health care reform), Poland (market access & IP), Russia WTO accession (market access), European Union (market access), Spain (IP), Japan (pricing & regulatory reform), Korea FTA (pricing, regulatory & IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price control), Turkey (transparency & market access), Algeria (transparency), Latin America Free Trade Agreements, Canada (market access -- S 242), Norway (market access), China (pricing)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2008 · second_quarter · Q2
Agriculture
United Kingdom (pricing reform), Italy (pricing and health care reform), Germany (pricing and health care reform), France (pricing and health care reform), Poland (market access & IP), Russia WTO accession (market access), European Union (market access), Spain (IP), Japan (pricing & regulatory reform), Korea FTA (pricing, regulatory & IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price control), Turkey (transparency & market access), Algeria (transparency), Latin America Free Trade Agreements, Canada (market access -- S 242), Norway (market access), China (pricing)
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)
ELI LILLY AND COMPANY via ELI LILLY AND COMPANY
2008 · second_quarter · Q2
United Kingdom (pricing reform), Italy (pricing and health care reform), Germany (pricing and health care reform), France (pricing and health care reform), Poland (market access & IP), Russia WTO accession (market access), European Union (market access), Spain (IP), Japan (pricing & regulatory reform), Korea FTA (pricing, regulatory & IP), ASEAN (regulatory harmonization), Thailand (CLs), Philippines (price control), Turkey (transparency & market access), Algeria (transparency), Latin America Free Trade Agreements, Canada (market access -- S 242), Norway (market access), China (pricing)
Appropriations Bill
Filing targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR)